Drugs for neurologic, psychiatric conditions up smokers’ nicotine metabolism
September 19th, 2010 - 3:47 pm ICT by ANIWashington, Sep 19 (ANI): Carbamazepine and oxycarbamazepine, medications commonly used to treat neurologic and psychiatric conditions, increase nicotine metabolism in smokers, UMDNJ-Robert Wood Johnson Medical School researchers have found.
As nicotine metabolism increases, cravings for nicotine return more quickly which could lead to more frequent cigarette consumption among individuals who also take these medications.
The study examined the effects of three anti-epileptic drugs - carbamazepine, oxcarbazepine and valproic acid - on nicotine and nicotine metabolite levels in 149 smokers with schizophrenia and bipolar disorder.
Smoking is more prevalent in people with serious forms of mental illnesses, such as schizophrenia and bipolar disorder, than in the general population, explained Kunal K. Gandhi, M.B.B.S., M.P.H., an instructor of psychiatry at the UMDNJ-Robert Wood Johnson Medical School and study co-author.
“The effect of these medications may have serious implications on nicotine metabolism and smoking behavior,” Williams added.
“Anti-epileptic drugs (AED) are of particular concern with respect to drug interactions because of their potential to induce many hepatic cytochrome P450 enzymes and increases nicotine metabolism,” Williams explained. (ANI)
- Anti-epileptic drugs 'increase risk of fracture in older adults' - Jan 11, 2011
- Breast cancer survivors at increased second cancer risk if they smoke - May 03, 2010
- How cigarette smoke affects smokers - Apr 07, 2011
- Menthol cigarettes more addictive - Jan 10, 2009
- Lactate's role in development of breast cancer - Apr 19, 2010
- Mouse study shows nicotine does not promote lung cancer growth - Apr 05, 2011
- Kids born to smoking mums 'more likely to become smokers' - Mar 22, 2011
- How second-hand smoke may increase vulnerability to nicotine addiction - May 03, 2011
- Common anxiety disorders make it tougher to kick the butt - Oct 26, 2010
- Novel peptide 'kills' cancer cells more effective than current therapies - Jan 23, 2011
- Long-term lung cancer survivors' breathlessness woes - Aug 03, 2010
- Smoking can reduce thickness of the brain - Dec 03, 2010
- Different genes behind smoking risk in adolescence and adulthood - Apr 01, 2011
- Epileptic mums' teens display poor school performance: Study - Nov 04, 2010
- Indian origin scientist wins prestigious 'New Innovator Award' - Sep 26, 2009
Tags: anti epileptic drugs, carbamazepine, cigarette consumption, hepatic, johnson medical school, kunal, medical school researchers, mental illnesses, metabolite levels, nicotine, nicotine metabolism, oxcarbazepine, p450 enzymes, psychiatric conditions, robert wood johnson medical school, schizophrenia, smokers, umdnj, valproic acid, wood johnson medical school